Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
» Ahead of Novartis deal, GlaxoSmithKline scoops up vaccine developer in $190M buyout
Ahead of Novartis deal, GlaxoSmithKline scoops up vaccine developer in $190M buyout
Ahead of Novartis deal, GlaxoSmithKline scoops up vaccine developer in $190M buyout
Submitted by
admin
on February 11, 2015 - 8:00am
Source:
Fierce Biotech
News Tags:
GSK
Novartis
vaccines
M&A
GlycoVaxyn
Headline:
Ahead of Novartis deal, GlaxoSmithKline scoops up vaccine developer in $190M buyout
Do Not Allow Advertisers to Use My Personal information
